Aim: To prospectively investigate, during a 5-year follow-up, whether the prognosis of thyroid function with Hashimoto thyroiditis (HT) is different in euthyroid girls with Turner syndrome (TS) than in euthyroid girls without TS. Design: In 66 TS girls and 132 non-TS girls with euthyroid HT and similar thyroid functional test results at HT diagnosis, we followed up the evolution of thyroid status over time. Results: At the end of follow-up, the TS girls exhibited higher TSH levels, lower fT4 levels, and lower prevalence rates of both euthyroidism and subclinical hypothyroidism, but higher prevalence rates of both overt hypothyroidism and hyperthyroidism, irrespective of the karyotype. Conclusions: An association with TS is able to impair the long-term prognosis of thyroid function in girls with HT. Such an effect occurs irrespective of thyroid functional test results at HT diagnosis and is not necessarily linked with a specific karyotype.

Keywords:
Autoimmune thyroid disorders, Chromosomopathies, Euthyroidism, Hyperthyroidism, Overt hypothyroidism, Subclinical hypothyroidism, Thyroid dysfunction
1.
Livadas S, Xekouki P, Fouka F, Kanaka-Gantenbein C, Kaloumenou I, Mavrou A, Constantinidou N, Dacou-Voutetakis C: Prevalence of thyroid dysfunction in Turner's syndrome: a long-term follow-up study and brief literature review. Thyroid 2005;15:1061-1066.
2.
Fukuda I, Hizuka N, Kurimoto M, Morita J, Tanaka S, Yamakado Y, Takano K: Autoimmune thyroid diseases in 65 Japanese women with Turner syndrome. Endocr J 2009;56:983-986.
3.
Larizza D, Calcaterra V, Martinetti M: Autoimmune stigmata in Turner syndrome: when lacks an X chromosome. J Autoimmun 2009;33:25-30.
4.
Grossi A, Crinò A, Luciano R, Lombardo A, Cappa M, Fierabracci A: Endocrine autoimmunity in Turner syndrome. Ital J Pediatr 2013;39:79-86.
5.
Bakalov VK, Cheng C, Zhou J, Bondy CA: X-chromosome gene dosage and the risk of diabetes in Turner syndrome. J Clin Endocrinol Metab 2009;94:3289-3296.
6.
Jørgensen KT, Rostgaard K, Bache I, Biggar RJ, Nielsen NM, Tommerup N, Frisch M: Autoimmune diseases in women with Turner's syndrome. Arthritis Rheum 2010;62:658-666.
7.
Lleo A, Moroni L, Caliari L, Invernizzi P: Autoimmunity and Turner's syndrome. Autoimmun Rev 2012;11:A538-A543.
8.
Radetti G, Mazzanti L, Paganini C, Bernasconi S, Russo G, Rigon F, Cacciari E: Frequency, clinical and laboratory features of thyroiditis in girls with Turner's syndrome. The Italian Study Group for Turner's Syndrome. Acta Paediatr 1995;84:909-912.
9.
Chiovato L, Larizza D, Bendinelli G, Tonacchera M, Marinó M, Mammoli C, Lorini R, Severi F, Pinchera A: Autoimmune hypothyroidism and hyperthyroidism in patients with Turner's syndrome. Eur J Endocrinol 1996;134:568-575.
10.
Elsheikh M, Wass JA, Conway GS: Autoimmune thyroid syndrome in women with Turner's syndrome - the association with karyotype. Clin Endocrinol 2001;55:223-226.
11.
Gawlik A, Gawlik T, Januszek-Trzciakowska A, Patel H, Malecka-Tendera E: Incidence and dynamics of thyroid dysfunction and thyroid autoimmunity in girls with Turner's syndrome: a long-term follow-up study. Horm Res Paediatr 2011;76:314-320.
12.
Aversa T, Messina MF, Mazzanti L, Salerno M, Mussa A, Faienza MF, Scarano E, De Luca F, Wasniewska M: The association with Turner syndrome significantly affects the course of Hashimoto's thyroiditis in children, irrespective of karyotype. Endocrine 2015;50:777-782.
13.
Arrigo T, Wasniewska M, Crisafulli G, Lombardo F, Messina MF, Rulli I, Salzano G, Valenzise M, Zirilli G, De Luca F: Subclinical hypothyroidism: the state of the art. J Endocrinol Invest 2008;31:79-84.
14.
Cooper DS: Clinical practice. Subclinical hypothyroidism. N Engl J Med 2001;345:260-265.
15.
Lazarus J, Brown RS, Daumerie C, Hubalewska-Dydejczyk A, Negro R, Vaidya B: European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. Eur Thyroid J 2014;3:76-94.
16.
Wasniewska M, Corrias A, Salerno M, Mussa A, Capalbo D, Messina MF, Aversa T, Bombaci S, De Luca F, Valenzise M: Thyroid function patterns at Hashimoto's thyroiditis presentation in childhood and adolescence are mainly conditioned by patients' age. Horm Res Paediatr 2012;78:232-236.
17.
Wasniewska M, Corrias A, Aversa T, Valenzise M, Mussa A, De Martino L, Lombardo F, De Luca F, Salerno M: Comparative evaluation of therapy with L-thyroxine versus no treatment in children with idiopathic and mild subclinical hypothyroidism. Horm Res Paediatr 2012;77:376-381.
18.
Radetti G, Gottardi E, Bona G, Corrias A, Salardi S, Loche S; Study Group for Thyroid Diseases of the Italian Society for Pediatric Endocrinology and Diabetes (SIEDP/ISPED): The natural history of euthyroid Hashimoto's thyroiditis in children. J Pediatr 2006;149:827-832.
19.
Demirbilek H, Kandemir N, Gonc EN, Ozon A, Alikasifoglu A: Assessment of thyroid function during the long course of Hashimoto's thyroiditis in children and adolescents. Clin Endocrinol (Oxf) 2009;71:451-454.
20.
Aversa T, Lombardo F, Valenzise M, Messina MF, Sferlazzas C, Salzano G, De Luca F, Wasniewska M: Peculiarities of autoimmune thyroid diseases in children with Turner or Down syndrome: an overview. Ital J Pediatr 2015;41:39.
21.
Wasniewska M, Aversa T, Salerno M, Corrias A, Messina MF, Mussa A, Capalbo D, De Luca F, Valenzise M: Five-year prospective evaluation of thyroid function in girls with subclinical mild hypothyroidism of different etiology. Eur J Endocrinol 2015;173:801-808.
22.
Aversa T, Salerno M, Radetti G, Faienza MF, Iughetti L, Corrias A, Predieri B, Mussa A, Mirabelli S, De Luca F, Wasniewska M: Peculiarities of presentation and evolution over time of Hashimoto's thyroiditis in children and adolescents with Down's syndrome. Hormones 2015;14:410-416.
23.
Popova G, Paterson WF, Brown A, Donaldson MD: Hashimoto's thyroiditis in Down's syndrome: clinical presentation and evolution. Horm Res 2008;70:278-284.
24.
Goday-Arno A, Cerda-Esteva M, Flores-Le-Roux JA, Chillaron-Jordan JJ, Corretger JM, Cano-Pérez JF: Hyperthyroidism in a population with Down syndrome (DS). Clin Endocrinol (Oxf) 2009;71:110-114.
25.
Champion B, Gopinath B, Ma G, El-Kaissi S, Wall JR: Conversion to Graves' hyperthyroidism in a patient with hypothyroidism due to Hashimoto's thyroiditis documented by real-time thyroid ultrasonography. Thyroid 2008;18:1135-1137.
26.
Ludgate M, Emerson CH: Metamorphic thyroid autoimmunity. Thyroid 2008;18:1035-1037.
27.
Wasniewska M, Corrias A, Arrigo T, Lombardo F, Salerno M, Mussa A, Vigone MC, De Luca F: Frequency of Hashimoto's thyroiditis antecedents in the history of children and adolescents with Graves' disease. Horm Res Paediatr 2010;73:473-476.
28.
Kamath C, Young S, Kabelis K, Sanders J, Adlan MA, Furmaniak J, Rees Smith B, Premawardhana LD: Thyrotrophin receptor antibody characteristics in a woman with long-standing Hashimoto's who developed Graves' disease and pretibial myxoedema. Clin Endocrinol (Oxf) 2012;77:465-470.
29.
Troisi A, Novati P, Sali L, Colzani M, Monti G, Cardillo C, Tesauro M: Graves' thyrotoxicosis following Hashimoto's thyroiditis. Res Rep Endocr Disord 2013;3:13-15.
30.
Valenzise M, Aversa T, Corrias A, Mazzanti L, Cappa M, Ubertini G, Scarano E, Mussa A, Messina MF, De Luca F, Wasniewska M: Epidemiology, presentation and long-term evolution of Graves' disease in children, adolescents and young adults with Turner syndrome. Horm Res Paediatr 2014;81:245-250.
31.
Aversa T, Lombardo F, Corrias A, Salerno M, De Luca F, Wasniewska M: In young patients with Turner or Down syndrome, Graves' disease presentation is often preceded by Hashimoto's thyroiditis. Thyroid 2014;24:744-747.
32.
Aversa T, Valenzise M, Salerno M, Corrias A, Iughetti L, Radetti G, De Luca F, Wasniewska M: Metamorphic thyroid autoimmunity in Down syndrome: from Hashimoto's thyroiditis to Graves' disease and beyond. Ital J Pediatr 2015;41:87.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.